Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Ho...

FDA Drug Recall #D-0005-2022 — Class II — September 2, 2021

Recall Summary

Recall Number D-0005-2022
Classification Class II — Moderate risk
Date Initiated September 2, 2021
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm RISING PHARMACEUTICALS
Location East Brunswick, NJ
Product Type Drugs
Quantity 1,344 bottles

Product Description

Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01

Reason for Recall

Labeling: Incorrect Instructions

Distribution Pattern

to be entered

Lot / Code Information

Lot # CB21024, Exp 2/2023

Other Recalls from RISING PHARMACEUTICALS

Recall # Classification Product Date
D-0348-2023 Class II Warfarin Sodium Tablets, USP 1 mg, 100-count bo... Feb 15, 2023
D-0573-2022 Class II Methylphenidate Hydrochloride Chewable Tablets,... Feb 7, 2022

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.